TABLE OF CONTENTS
Volume 12, Issue 2 (January 2005)
Review
Gene Therapy Progress and Prospects: Gene therapy for diabetes mellitus
V Yechoor and L Chan
Gene Ther 12: 101-107; advance online publication, October 21, 2004; doi:10.1038/sj.gt.3302412
Research Articles
Adenoviral clostridial light chain gene-based synaptic inhibition through neuronal synaptobrevin elimination
Q Teng, D K Tanase, J K Liu, M E Garrity-Moses, K B Baker and N M Boulis
Gene Ther 12: 108-119; advance online publication, October 21, 2004; doi:10.1038/sj.gt.3302400
Adenoviral overexpression of interleukin-1 receptor antagonist protein increases 
-cell replication in rat pancreatic islets
N Téllez, M Montolio, M Biarnés, E Castaño, J Soler and E Montanya
Gene Ther 12: 120-128; advance online publication, December 2, 2004; doi:10.1038/sj.gt.3302351
Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction
N Okada, N Mori, R Koretomo, Y Okada, T Nakayama, O Yoshie, H Mizuguchi, T Hayakawa, S Nakagawa, T Mayumi, T Fujita and A Yamamoto
Gene Ther 12: 129-139; advance online publication, October 14, 2004; doi:10.1038/sj.gt.3302358
Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR 
gene transfer requires CD8
R Willemsen, C Ronteltap, M Heuveling, R Debets and R Bolhuis
Gene Ther 12: 140-146; advance online publication, October 21, 2004; doi:10.1038/sj.gt.3302388
Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector
J W P Smyth, M N Fleeton, B J Sheahan and G J Atkins
Gene Ther 12: 147-159; advance online publication, September 16, 2004; doi:10.1038/sj.gt.3302390
Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice
F-D Cui, H Asada, M-L Jin, T Kishida, M Shin-Ya, T Nakaya, M Kita, M Ishii, M Iwai, T Okanoue, J Imanishi and O Mazda
Gene Ther 12: 160-168; advance online publication, October 7, 2004; doi:10.1038/sj.gt.3302393
Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase
V Roy, J Qiao, P de Campos-Lima and M Caruso
Gene Ther 12: 169-176; advance online publication, October 14, 2004; doi:10.1038/sj.gt.3302394
Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy
A J Nixon, J L Haupt, D D Frisbie, S S Morisset, C W McIlwraith, P D Robbins, C H Evans and S Ghivizzani
Gene Ther 12: 177-186; advance online publication, December 2, 2004; doi:10.1038/sj.gt.3302396
Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy
M Breidenbach, D T Rein, M Everts, J N Glasgow, M Wang, M J Passineau, R D Alvarez, N Korokhov and D T Curiel
Gene Ther 12: 187-193; advance online publication, November 4, 2004; doi:10.1038/sj.gt.3302404
